For the first time, medical groups have issued guidelines that say healthy older men should consider taking a drug that may reduce their risk of developing prostate cancer, even if they're just among the worried well who go in for regular screenings.\n\nThe drug, finasteride, is already used to treat male pattern baldness and to shrink enlarged prostates. The new guidelines suggest that patients who are already taking finasteride for those conditions or who go for regular prostate cancer screening tests should discuss long-term treatment with the drug with their doctors.
Three leading U.S. cancer groups have proposed new guidelines for cervical cancer testing for women, including when to start screening for sexually active young women, extending intervals between screenings and in some cases, supplementing the traditional Pap test with human papilloma virus (HPV) testing.
Researchers say a combination of biomarkers may offer insights to build a noninvasive screening tool for pancreatic cancer as it related to new-onset diabetics.
Not enough vitamin D: health consequences for Canadians.
Schwalfenberg G.
Can Fam Physician. 2007 May;53(5):841-54. Review
PMID: 17872747
Conclusion
Low levels of VTD are considered a major public health problem in Canada, especially during the winter. Those with risk factors should be screened for low 25(OH)D levels and repletion therapy instituted if needed. Researchers have estimated that the oral dose of vitamin D3 to attain and maintain 25(OH)D levels >80 nmol/L is 2200 IU/d if baseline levels are 20 to 40 nmol/L, 1800 IU/d if levels are 40 to 60 nmol/L, and 1160 IU/d if levels are between 60 and 80 nmol/L.64
We need to ensure that patients have healthy blood levels of 25(OH)D to prevent levels of parathyroid hormone from rising and to maximize absorption of calcium, magnesium, and phosphate. Positive effects on bone are marginal at best unless patients consume at least 800 IU/d of VTD. The emerging and exciting role of the VTD receptor and the actions of VTD in maintaining health in other cell types have become more apparent during the last decade.
Creative BioLabs is an US based biotech service provider.It has extensive experience in internalizing antibody and peptides. Call 1-631-871-5806 or email at contact@creative-biolabs.com for details.
Can sniffer dog detection take the place of traditional prostate cancer screening like immunized human antibody library ? It is still too early to draw a conclusion at present. Nobody knows how this sniffer dog detection technology can be applied to clinical use, or whether it can be widely promoted.
Online Cancer blog tracks information on the advances in the study of cancers, and also other aspects of cancer related issues that concerns majority of people. Learn the latest information and treatment methods on prostate cancer, breast cancer, lung cancer, skin cancer, colon cancer, ovarian cancer, pancreatic cancer, liver cancer, throat cancer.
The recommendations, to be officially announced on Tuesday by the United States Preventive Services Task Force, affect more than 44 million men age 50 and older who typically are candidates for a simple blood screen call the prostate-specific antigen (P.S.A.) test.
Scientists advising the government say a Pap test is a good way to screen young and middle-aged women for cervical cancer, and it's only needed once every three years.
Once you start, it's important to keep up with screenings. The National Cancer Institute estimates that more than 230,000 new cases of breast cancer will be diagnosed this year.